The second trial is conducted in a group of 100 patients who each have only one risk factor for a heart attack, and so are classed as having a low baseline risk.
Without treatment, only 3 patients out of this low risk group of 100 will experience a heart attack over the next 10 years The control event rate is 3%.
With Curit, the number of low risk patients who will experience a heart attack over the next 10 years falls to 2 patients out of 100. The experimental event rate is 2%.
Again we can express the magnitude of effect of Curit in trial 2 in two different ways:
Click the button on the media player, or click the banners above to move to part 5.